Published in Biokhimiia on June 01, 1980
The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate. Cardiovasc Hematol Agents Med Chem (2008) 1.28
What is vinculin needed for in platelets? J Thromb Haemost (2010) 0.90
[Fibronectin receptors on the surfaces of alveolar macrophages]. Tsitologiia (1983) 0.76
Cell microvesicles during experimental endotoxemia. Bull Exp Biol Med (2006) 0.76
Effect of blood microparticles on the kinetics of polymerization and enzymatic hydrolysis of fibrin. Dokl Biochem Biophys (2015) 0.76
Additional considerations on measuring the binding strength of single ligand-receptor pairs on cells: reply to a rebuttal. J Thromb Haemost (2004) 0.75
Measuring the binding strength of single ligand-receptor pairs on cells: rebuttal. J Thromb Haemost (2004) 0.75
[Circulation of soluble fibrin monomer in the body]. Vopr Med Khim (1978) 0.75
[Disorder of the adaptation possibilities of the circulatory system in radiation injury]. Radiobiologiia (1966) 0.75
[Relation between disseminated intravascular coagulation of blood and the level of plasma fibronectin in burn shock]. Patol Fiziol Eksp Ter (1989) 0.75
[Dynamics of 5'-nucleotidase activity in the blood plasma in experimental myocardial infarct]. Kardiologiia (1981) 0.75
[Role of the Hageman factor in regulation of blood coagulability]. Fiziol Zh SSSR Im I M Sechenova (1972) 0.75
[Circulation of tissue thromboplastin in the blood]. Fiziol Zh SSSR Im I M Sechenova (1984) 0.75
[Interaction of Hageman's factor with surfaces]. Probl Gematol Pereliv Krovi (1971) 0.75
[The determination of tissue thromboplastin activity in cells]. Lab Delo (1991) 0.75
[Effect of Glycine max lectin on the interaction of prothrombin and erythrocytes]. Vopr Med Khim (1997) 0.75
[Continuous blood coagulation in the body]. Probl Gematol Pereliv Krovi (1974) 0.75
[Distribution of thromboplastic and 5'-nucleotidase activity in human liver]. Vopr Med Khim (1983) 0.75
[Interaction of lectins with tissue thromboplastin]. Gematol Transfuziol (1990) 0.75
[Contact phase of blood coagulation and formation of thrombi in the blood vessel prosthesis]. Eksp Khir Anesteziol (1975) 0.75
[Effect of immobilized noradrenaline on the contact phase of blood coagulation]. Vopr Med Khim (1977) 0.75
[Effect of enzymes involved in the contact phase of blood clotting on the functional activity of neutrophils related to phagocytosis]. Biull Eksp Biol Med (1978) 0.75
[Matrix hypotheses of the enzymatic cascade in blood coagulation]. Probl Gematol Pereliv Krovi (1980) 0.75
[Interaction of human prothrombin with tissue thromboplastin]. Biokhimiia (1989) 0.75
[Specificity and sensitivity of paracoagulation tests]. Lab Delo (1980) 0.75
[Electrophoresis of the plasminogen activators]. Lab Delo (1973) 0.75
[Biochemical basis of a fibrinogen B test (a discussion of V. K. Peters' article, "The Quantitative Determination of Fibrinogen B")]. Lab Delo (1980) 0.75
[The expression and degradation of tissue thromboplastin]. Fiziol Zh SSSR Im I M Sechenova (1988) 0.75
[Diagnosis of thromboplastinemia in myocardial infarct]. Ter Arkh (1981) 0.75
[The role of lipid peroxidation in the process of thermal inactivation of tissue thromboplastin]. Vopr Med Khim (1987) 0.75
[General recommendations for laboratory work in studying blood coagulability]. Klin Lab Diagn (1998) 0.75
[Isolation and characteristics of fibronectin from fibrinolytically active human plasma]. Vopr Med Khim (1992) 0.75
[THROMBIN-MEDIATED EFFECTS OF BLOOD MICROPARTICLES ON FORMATION, STRUCTURE, AND STABILITY OF FIBRIN CLOTS]. Ross Fiziol Zh Im I M Sechenova (2015) 0.75
[The role of plasma fibronectin in the pathogenesis of post- aggressive conditions]. Gematol Transfuziol (1992) 0.75
[Blood coagulation properties of Kupffer's cells]. Biull Eksp Biol Med (1970) 0.75
[Modification effect of the protein component of tissue thromboplastin (factor III) on its interaction with factors VII and X]. Biokhimiia (1984) 0.75
[Quantitative and qualitative changes in the fibronectin level in rheumatoid arthritis]. Ter Arkh (1988) 0.75
[Participation of alveolar macrophages in the catabolism of fibrinogen and fibrin]. Biull Eksp Biol Med (1989) 0.75
[Clinical importance of fibronectin research in rheumatoid arthritis]. Revmatologiia (Mosk) (1989) 0.75
[Hemocoagulation properties of the vascular wall in dicoumarin induced hemorrhagic diathesis]. Patol Fiziol Eksp Ter (1972) 0.75
[Studies on the glycopeptides of canine prothrombin]. Biokhimiia (1977) 0.75
[Distribution and inactivation of tissue thromboplastin in the body]. Gematol Transfuziol (1988) 0.75
[Effect of exogenous fibronectin on the healing of skin wounds as evidenced by tensiometric data]. Biull Eksp Biol Med (1987) 0.75
[Effect of modifications of the protein moiety of thromboplastin (factor III) on its activity]. Biokhimiia (1981) 0.75
[The rate of physiological fibrinolysis in the mesenteric and renal vessels of rabbits]. Fiziol Zh Im I M Sechenova (1996) 0.75
Effect of radiation on prothrombin interactions with cell membrane fragments. Bull Exp Biol Med (2002) 0.75
[Determining fibronectin levels for the evaluation of the wound healing process]. Khirurgiia (Mosk) (1986) 0.75
[Role of vascular and thrombocyte membranes in hypercoagulemia]. Kardiologiia (1974) 0.75
[Noncoagulative catabolism of fibrinogen]. Vopr Med Khim (1975) 0.75
[Effect of immobilized noradrenaline on human plasma arginine esterase activated by factor XII]. Biokhimiia (1977) 0.75
[Device for illuminating objects in transmitted light for the purpose of photography]. Lab Delo (1980) 0.75
[A rare case of congenital hypodysfibrinogenemia]. Gematol Transfuziol (1985) 0.75
[Effect of lysozyme suppression of factor XII activation on postadrenaline hypercoagulation]. Fiziol Zh SSSR Im I M Sechenova (1980) 0.75
[Molecular weight of human native factor XII (Hageman factor)]. Dokl Akad Nauk SSSR (1974) 0.75
[Effect of a factor XII inhibitor isolated from kernels of corn on the cold activation of factor VII in blood plasma]. Gematol Transfuziol (1986) 0.75
[2 simple methods of detecting fibrin degradation products in blood]. Lab Delo (1982) 0.75
[The effect of lysozyme, ribonuclease and cytochrome C on the activation of one of the blood coagulation factors--the Hageman factor--by adrenaline]. Ukr Biokhim Zh (1973) 0.75
[Functional concept of the initiation of blood coagulation by cell membranes]. Gematol Transfuziol (1991) 0.75
[Role of Kupffer cells and hepatocytes in fibrinogen catabolism]. Vopr Med Khim (1982) 0.75
[Interaction of human thrombin I fragment, prethrombin I, and alpha-thrombin with tissue thromboplastin]. Biokhimiia (1992) 0.75
[Characteristics of proteins precipitated from pathologic human blood plasma with ethanol and beta-naphthol]. Vestn Akad Med Nauk SSSR (1981) 0.75
[Interaction of prothrombin with erythrocytes and alveolar macrophages]. Gematol Transfuziol (1994) 0.75
[Role of the reticuloendothelial system in the catabolism of fibrinogen]. Fiziol Zh SSSR Im I M Sechenova (1978) 0.75
[Plasma fibronectin in experimental combined mechanical trauma, complicated by disseminated intravascular coagulation]. Ortop Travmatol Protez (1990) 0.75
[Blood coagulating properties of immobilized proteases]. Vopr Med Khim (1977) 0.75
[Mechanism of nonenzymatic fibrinolysis]. Vopr Med Khim (1981) 0.75
[Effect of fibronectin on fibrinogen conversion into fibrin]. Biokhimiia (1988) 0.75
[Hemocoagulation and fibrinolytic properties of alkaline phosphatase]. Probl Gematol Pereliv Krovi (1975) 0.75
New evidence for the activation of factor XII by epinephrine. Thromb Res (1976) 0.75
[Reactions initiating blood coagulation]. Ukr Biokhim Zh (1978) (1983) 0.75
[The indications for lymphogenic antibiotic therapy in peritonitis and its efficacy]. Vestn Khir Im I I Grek (1992) 0.75
[Interaction of fibronectin with polymorphonuclear leukocytes normally and in anaphylaxis]. Biull Eksp Biol Med (1986) 0.75
Characterization of the ethanol and beta-naphthol precipitable proteins from pathological human plasma. Thromb Res (1981) 0.75
[Fractional composition of fibrinogen B]. Lab Delo (1977) 0.75
[Fibronectin and fibronectin receptors on the surfaces of polymorphonuclear leukocytes]. Biull Eksp Biol Med (1982) 0.75
[Interaction of alveolar macrophages with fibronectin during sensitization and anaphylactic shock]. Biull Eksp Biol Med (1985) 0.75
[Irreversible pH-denaturation of tissue thromboplastin]. Vopr Med Khim (1992) 0.75
[Blood fibronectin level in experimental burn shock]. Ter Arkh (1984) 0.75
[Carbohydrate composition and properties of dog prothrombin]. Zh Evol Biokhim Fiziol (1974) 0.75
[Effects of fibronectin instillation on reparative regeneration of the corneal tissue (an experimental study)]. Vestn Oftalmol (1990) 0.75
[STRUCTURAL CHARACTERIZATION OF PLATELETS AND PLATELET-DERIVED MICROVESICLES]. Tsitologiia (2016) 0.75
[Complex-formation with hyaluronic acid as a cause of fibronectin heterogeneity in the synovial fluid]. Vopr Med Khim (1987) 0.75
[Are positive paracoagulation tests at room temperature an artefact?]. Lab Delo (1982) 0.75
[Adrenaline-induced release from thrombocytes of beta-lipoprotein, alkaline phosphatase and 5'-nucleotidase]. Biull Eksp Biol Med (1976) 0.75
[Physiological intravascular activation of blood coagulation]. Gematol Transfuziol (1983) 0.75
[Role of cathepsin C in blood coagulation]. Vopr Med Khim (1972) 0.75
Effect of lupus anticoagulant on the interaction of prothrombin with platelets. Bull Exp Biol Med (2004) 0.75
[Mechanism of the effect of immobilized noradrenaline on the contact phase of blood coagulation]. Vopr Med Khim (1979) 0.75
[Interaction of human factor X with thromboplastin]. Biomed Khim (2005) 0.75
[Determination of C-terminal amino acid content in dog prothrombin]. Ukr Biokhim Zh (1978) (1978) 0.75
[Canine fibrinogen glycopeptides]. Biokhimiia (1980) 0.75